Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML [Phase 3]
A Phase 3 clinical trial comparing conditioning with cytoablative chemotherapy (CBA) versus family-blood-availability (FBA) conditioning fol…
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) [Phase 1]
Phase 1 trial evaluating milademetan alone and with 5-azacitidine in acute myeloid leukemia or high-risk myelodysplastic syndrome; study ter…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia [Phase 3]
Phase III international randomized trial in children with acute myeloid leukaemia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial evaluating idarubicin, cytarabine, and nivolumab in high-risk myelodysplastic syndrome and acute myeloid leukemia; study com…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations [Phase 3]
Phase 3 trial of crenolanib in combination with chemotherapy for relapsed or refractory acute myeloid leukemia with activating FLT3 mutation…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia [Phase 1, Phase 2]
Clinical trial updates the use of peginterferon alfa-2a to enhance anti-leukemic responses after allogeneic transplantation in acute myeloid…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia [Phase 2]
Phase 2 trial update on a targeted therapy for relapsed/refractory acute lymphoblastic leukemia and acute myeloid leukemia; trial status ter…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT [Phase 1, Phase 2]
Clinical trial update on ex-vivo primed memory donor lymphocyte infusion to boost antiviral immunity after T-cell depleted hematopoietic ste…
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) [Phase 1, Phase 2]
Phase 1/2 trial investigating Max-40279-01 with azacitidine for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemia; saf…
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old [Phase 3]
A Phase 3 clinical trial comparing induction therapies DA-90 vs DAC and salvage regimens FLAG-IDA vs CLAG-M in adults up to 60 with Acute My…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 clinical trial evaluating a conditioning regimen (busulfan, melphalan, fludarabine) with peri-transplant palifermin followed by T-ce…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia [Phase 2]
Phase 2 trial evaluating isavuconazole for preventing invasive fungal infections in adults with newly diagnosed acute myeloid leukemia or my…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating dasatinib, cytarabine, and idarubicin in high-risk acute myeloid leukemia was terminated; results post…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluating ulocuplumab plus low-dose cytarabine in newly diagnosed acute myeloid leukemia was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 3]
Phase 3 trial of idasanutlin with cytarabine in relapsed/refractory AML was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement [Phase 1, Phase 2]
Phase 1/2 trial evaluating pinometostat and azacitidine in patients with 11q23/MLL rearranged AML across relapsed, refractory, or newly diag…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML [Phase 2]
Phase 2 trial evaluating high-dose cytarabine followed by pembrolizumab in relapsed/refractory acute myeloid leukemia has completed with res…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS [Phase 2]
Phase II study evaluating azacitidine with sargramostim as maintenance therapy for poor-risk AML or MDS has completed; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) [Phase 2]
Phase II trial evaluating selinexor with cytarabine and idarubicin in relapsed/refractory acute myeloid leukemia has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 1]
This is a Phase 1 trial evaluating quizartinib in Japanese patients with newly diagnosed acute myeloid leukemia; the study has completed and…
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial [Phase 1, Phase 2]
Rollover extension study for subjects who participated in an ASP2215 (gilteritinib) trial, enrolling patients with acute myeloid leukemia; s…
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid [Phase 2]
Phase 2 trial updating TET2 mutation targeting with azacitidine plus ascorbic acid in myelodysplastic syndromes and acute myeloid leukemia h…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML [Phase 2]
Phase II study evaluating pembrolizumab as post-remission treatment in adults aged ≥60 with acute myeloid leukemia has completed accrual and…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World
A completed real-world study evaluating treatment patterns and outcomes in acute myeloid leukemia patients who received Mylotarg (gemtuzumab…
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Eltrombopag in Elderly Acute Myelogenous Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial of eltrombopag in elderly patients with acute myeloid leukemia has been terminated; results posted in 2021.